Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin-diabetic rats

Archiv der Pharmazie

Volumn 334, Issue 12, 2001, Pages 388-392

  Krosniak, Miroslaw ^a,b   Zachwieja, Zofia ^a,b   Filipek, Barbara ^a   Zygmunt, Malgorzata ^a,b   Grybos, Ryszard ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cholesterol; Glucose; STZ diabetic rats; Vanadium compounds

Indexed keywords

AQUADICHLOROBIS(2 HYDROXY 1 METHYL 1 CYCLOPENTEN 3 ON)OXOVANADIUM; BIS(1,10 PHENANTHROLINE)OXOVANADIUM SULFATE; BIS(2,2' BIPYRIDINE)OXOVANADIUM SULFATE; CHOLESTEROL; GLUCOSE; LIPID; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; GLUCOSE BLOOD LEVEL; INFRARED SPECTROSCOPY; LIPID BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TOXICITY;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; LIPIDS; MALE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; STREPTOZOCIN; STRUCTURE-ACTIVITY RELATIONSHIP; VANADATES;

EID: 0035704438     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4184(200112)334:12<388::AID-ARDP388>3.0.CO;2-9     Document Type: Article

References (33)